Physicians for Human Rights finds US funding cuts hinder South Africa HIV prevention
Updated
Updated · Reuters · Apr 21
Physicians for Human Rights finds US funding cuts hinder South Africa HIV prevention
10 articles · Updated · Reuters · Apr 21
The report highlights that US aid cuts have disrupted HIV prevention just as lenacapavir, a new injectable drug, arrives in South Africa, home to 8 million HIV-infected people.
Community outreach and counseling programs funded by the US have been dismantled, making it harder for vulnerable groups to access new prevention options like lenacapavir.
Physicians for Human Rights warns that years of US investment are at risk, with data collection also impacted, while declines in HIV testing and diagnoses have been observed despite official claims of stable aid.
With data collection cut, is Africa flying blind into a new HIV surge?
How will South Africa's youth access HIV prevention without community outreach?
Why do new U.S. health deals require African nations to share biological data?
A breakthrough HIV drug has arrived, but is its delivery system gone?
Can a 'trade over aid' health strategy actually fight a global pandemic?